Cell-Free DNA Methylation Liquid Biopsy Discriminates Ovarian Cancer

THURSDAY, Oct. 19, 2023 -- A classifier based on cell-free DNA (cfDNA) methylation liquid biopsy can discriminate high-grade serous ovarian carcinoma (HGSOC) from benign masses, according to a study published online Oct. 9 in Clinical Cancer...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news